Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Zachou

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Rheumatology Reports|July 27, 2001
The antiphospholipid syndrome and infectionG N Dalekos, K Zachou, C Liaskos
European Journal of Internal Medicine|July 30, 2002
Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overviewG N. Dalekos, K Zachou, C Liaskos, et al.
Autoimmune Diseases|June 21, 2011
Multiple autoimmune propensity and B-non-hodgkin lymphoma: cause or effect?E Koumati, M Palassopoulou, P Matsouka, et al.
Alimentary Pharmacology & Therapeutics|November 5, 2011
Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1K Zachou, K Oikonomou, Y Renaudineau, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2013
Review article: autoimmune hepatitis -- current management and challengesK Zachou, P Muratori, G K Koukoulis, et al.
Journal of Viral Hepatitis|July 3, 2004
Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseasesS P Georgiadou, K Zachou, E Rigopoulou, et al.
Clinical Nephrology|September 17, 2008
A case of membranous nephropathy associated with Sjögren syndrome, polymyositis and autoimmune hepatitisI Stefanidis, M Giannopoulou, V Liakopoulos, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2016
A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitisK Zachou, N K Gatselis, P Arvaniti, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2006
Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis CN K Gatselis, S P Georgiadou, G K Koukoulis, et al.
European Journal of Internal Medicine|September 15, 2001
Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practiceD K. Christodoulou, G N. Dalekos, M H. Merkouropoulos, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Rheumatology Reports|July 27, 2001
The antiphospholipid syndrome and infectionG N Dalekos, K Zachou, C Liaskos
European Journal of Internal Medicine|July 30, 2002
Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overviewG N. Dalekos, K Zachou, C Liaskos, et al.
Autoimmune Diseases|June 21, 2011
Multiple autoimmune propensity and B-non-hodgkin lymphoma: cause or effect?E Koumati, M Palassopoulou, P Matsouka, et al.
Alimentary Pharmacology & Therapeutics|November 5, 2011
Anti-α actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1K Zachou, K Oikonomou, Y Renaudineau, et al.
Alimentary Pharmacology & Therapeutics|September 10, 2013
Review article: autoimmune hepatitis -- current management and challengesK Zachou, P Muratori, G K Koukoulis, et al.
Journal of Viral Hepatitis|July 3, 2004
Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseasesS P Georgiadou, K Zachou, E Rigopoulou, et al.
Clinical Nephrology|September 17, 2008
A case of membranous nephropathy associated with Sjögren syndrome, polymyositis and autoimmune hepatitisI Stefanidis, M Giannopoulou, V Liakopoulos, et al.
Alimentary Pharmacology & Therapeutics|March 19, 2016
A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitisK Zachou, N K Gatselis, P Arvaniti, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2006
Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis CN K Gatselis, S P Georgiadou, G K Koukoulis, et al.
European Journal of Internal Medicine|September 15, 2001
Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practiceD K. Christodoulou, G N. Dalekos, M H. Merkouropoulos, et al.
Pageof 2